Zacks' 7 Best Stocks for June, 2013
FREE Report for Zacks.com
Visitors Only

They're hand-picked from the list of Zacks Rank #1 Strong Buys. Our experts predict that their prices will jump the soonest.

Today, you can see them free.

Close This Panel X

Are you a new Zacks Member or a visitor to Zacks.com?

Recent Quotes

No Recent Quote currently available

My Portfolio

My Portfolio Tracker

One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts. Set yours up today.

More Zacks Resources

Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.

Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.

Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.

My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.

Zacks #1 Stocks on the Move 05/17/2013

Company Name Symbol %Change
VIASAT INC VSAT
19.35%
OLD SECOND B OSBC
5.76%
GAMCO INVEST GBL
4.61%
CORNING INC GLW
4.47%
SYNCHRONOSS SNCR
4.23%

A.M. Best Rates Aetna Securities

by Zacks Equity Research

December 20, 2011 | Comments : 0 Recommended this article: (0)

This page is temporarily not available.  Please check later as it should be available shortly. If you have any questions, please email customer support at support@zacks.com or call 800-767-3771 ext.  9339.

Last week, rating agency A.M. Best Co. assigned ratings to Aetna’s ( ( AET - Analyst Report ) ) securities that were recently registered through the universal shelf registration process. The rating agency assigned a “bbb+” rating on the company’s senior unsecured debt, “bbb” on subordinated debt and “bbb-” on preferred stock with a stable outlook.

Shelf registration is a process authorized by the U.S. Securities and Exchange Commission (“SEC”), which allows a single registration document from a company for the issuance of multiple securities.

The proceeds from the securities’ issue are expected to be used for working capital, debt repayment, business development as well as other corporate purposes.

A.M. Best acknowledges Aetna’s strong operational and financial performance over the past years. Its broad product portfolio, with a range of traditional and consumer-directed health insurance products and related services, has helped it to establish the brand name.

Aetna’s position, in terms of its capital investments, is also viewed favorably by the rating agency. It boasts a strong balance sheet with sufficient financial flexibility and a debt-to-total capitalization ratio of 30%. Consistent positive cash flows, which are put to use for acquisitions, share repurchases or other strategic investments, generate value for both the business and the shareholders.

However, some of the factors that offset the positives include – negative pressure on margins and decline in enrollment numbers.

A. M. Best did not change the previously assigned ratings of Aetna and its subsidiaries. In June 2011, the rating agency had assigned “bbb+” debt ratings to the company’s $500 million 4.125% senior unsecured notes, due in 2021. The rating agency had also affirmed the financial strength ratings (“FSR”) of “A” and the issuer credit rating (“ICR”) of “a” for the company.

The financial strength and credit ratings of a company are important metrics to determine its ability to fulfill policyholder obligations. These also affect public confidence in the company’s potential and its competitiveness. Securing an investment grade debt rating with a stable outlook reflects optimism about Aetna’s future performance.

We also saw a similar rating action by A.M. Best last week when it assigned a “bbb+” rating to WellPoint Inc.’s ( WLP - Analyst Report ) senior unsecured debt, “bbb” to subordinated debt and “bbb-” to preferred stock with a stable outlook.

Aetna currently retains a Zacks #1 Rank, which translates into a short-term Strong Buy rating. Considering the fundamentals, we are also maintaining our long-term Outperform recommendation on the shares.

Email Print Share Rate Pos Rate Neg

Read/Post Comments (0) | Recommended this article (0)

Please login to Zacks.com or register to post a comment.

Zacks Research is Reported On:

Zacks Investment Research

is an A+ Rated BBB

Accredited Business.